$ESNT

Bhasin Vijay sold $34K of ESNT

Bhasin Vijay (SVP and Chief Risk Officer) sold 483 shares of Essent Group Ltd. (ESNT) at $70.00 on 2026-08-07 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bhasin Vijay
Published Aug 15, 2026, 12:06 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 15, 2026, 12:50 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ESNT
Neutral
high confidence
Mentioned
$ESNT
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ESNTNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price, and timing, plus confirmation it was executed under a pre-arranged 10b5-1 plan.

02

Market read

This is a routine insider sale disclosure with limited trading implications absent any other company catalyst.

03

What to watch

Traders may over-weight insider sales; without follow-on buys, guidance changes, or material events, the signal is typically weak.

Relevance 2/10Novelty 3/10Timing: SEC Form 4 filed 2026-08-14 for an 2026-08-07 sale.

Background

The article is an SEC Form 4 insider transaction disclosure for Essent Group Ltd., reported by SVP and Chief Risk Officer Bhasin Vijay.

Company-level read

Ticker impact

$ESNTNeutralHigh confidence
Context

Essent Group insider Bhasin Vijay sold 483 shares at $70 on 2026-08-07 under a pre-arranged 10b5-1 plan, per Form 4.

Expected impact

Low near-term impact; any reaction is likely limited and short-lived.

Evidence & confidence

The filing is a scheduled open-market sale under a 10b5-1 plan, with no accompanying company-specific operational or guidance change disclosed.

Market effects

No clear sector read-through from a single, small 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Because it is explicitly a pre-arranged 10b5-1 plan, the sale may reflect liquidity planning rather than bearish expectations.

Key entities

  • Essent Group Ltd.

    Subject of the Form 4 insider transaction disclosure.

  • Bhasin Vijay

    SVP and Chief Risk Officer who sold 483 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MKLMed

Winners And Losers Of Q2: Markel Group (NYSE:MKL) Vs The Rest Of The Property & Casualty Insurance Stocks

Markel Group (MKL) reported flat Q2 revenue ($4.02B) beating estimates by 1.1% but missed EPS and book value per share. Essent Group (ESNT) saw revenue rise 13.6% ($362.7M), beating estimates by 9.7%. Radian Group (RDN) revenue up 95.7% ($580.7M) but missed EPS. Kinsale Capital (KNSL) revenue up 16.8% ($548.5M), beating estimates by 14.9%. The Hanover (THG) revenue up 4% ($1.72B) but missed estimates by 0.5%.

$ESNTMedAI 8/10

Essent Group profit rises 7% as new P&C segment grows

Essent Group reported 2Q net income of $189.7 million, or $2.08 per diluted share, up from $177 million, or $1.93, a year earlier. Profit rose as its P&C reinsurance expansion increased premiums. P&C net premiums were $249 million for 1H 2026, and net premiums earned rose to $73 million. Essent expects $320 million written P&C premium in 2026 and declared a 35-cent quarterly dividend.

$ESNTMedAI 8/10

Essent Group (NYSE:ESNT) Delivers Strong Q2 CY2026 Numbers

Essent Group (NYSE:ESNT) reported Q2 2026 revenue of $362.7 million, up 13.6% year on year, beating Wall Street estimates by 9.7%. GAAP profit was $2.08 per share, 19.3% above consensus. The article also cites book value per share growth of about 11.7% over five years and notes the stock rose 2.4% to $67.08 after results.